Replies to post #407797 on Amarin Corp Plc (AMRN)

[couldbebetter]

Zip & Rose, "If" such a new drug or combo drug were possible,
I would rather it be launched by a BP that could rebrand it their way.
Of course, I would like to know the status of the Mochida one-a-day
version of Vascepa for the various jurisdictions. There is just so much
we do not know it is unlikely for any of us to know what makes sense
for AMRN to salvage the US market. At some point I would like to see
Sarissa increase their position in AMRN and have AMRN disclose
whatever their strategic plan is going to be going forward. Even if
AMRN were to say they cannot disclose any details, it would be
reassuring to know that they have an actual game-plan in place.